COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region

Autor: Rahma Mohamed, Trenton M. White, Jeffrey V. Lazarus, Amany Salem, Reham Kaki, Wafa Marrakchi, Sara G. M Kheir, Ibrahim Amer, Fida M Ahmed, Maie A Khayat, Nabeela Al-Abdullah, Batool Ali, Roaa Sultan, Bandar Alamri, Anouf Abdulmajid, Ikbal Kooli, Mohamed Chakroun, Tariq A. Madani, Gamal Esmat, Ahmed Cordie
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: Southern African Journal of HIV Medicine; Vol. 23 No. 1 (2022)
Southern African Journal of HIV Medicine, Volume: 23, Issue: 1, Pages: 1-9, Published: 2022
ISSN: 1608-9693
2078-6751
Popis: Background: Identifying coronavirus disease 2019 (COVID-19) vaccine acceptance and associated factors among people living with HIV (PLHIV) in the Middle East and North Africa region is important to meet the need for broad-scale vaccination against COVID-19. Objectives: To investigate the COVID-19 vaccine acceptance rate and factors among PLHIV in the Middle East and North Africa region. Method: An online cross-sectional survey was conducted among PLHIV currently living in Egypt, Tunisia and Saudi Arabia between March 2021 and August 2021. Results: Of the 540 respondents, 19.3% reported already being vaccinated against COVID-19 (n = 104), 32.0% responded ‘definitely yes’ (n = 173), and 13.3% responded ‘probably yes’ (n = 72) for intention to receive a COVID-19 vaccine, with an overall COVID-19 vaccine acceptance rate of 64.6% among PLHIV in the region. The most significant predictors of COVID-19 vaccine acceptance included feeling less worried about COVID-19 transmission post- vaccination (221.0% higher odds), and believing the disease is vaccine-preventable (160.0% higher odds). Reported barriers to COVID-19 vaccine acceptance include concerns about vaccine effectiveness and belief that HIV medications protect against COVID-19 transmission, living in a rural area and reporting less-frequent engagement with HIV care. Nine out of 10 participants reported that the chances of them getting COVID-19 vaccine would increase if given adequate information and if their doctor recommended it. Conclusion: Findings of the study can help researchers, health officials, and other health system actors understand the predictors and barriers to COVID-19 vaccine acceptance reported by PLHIV. This understanding could inform the future planning of interventions tailored to PLHIV. 
Databáze: OpenAIRE